10.6084/m9.figshare.12206147.v1 Lu Wang Lu Wang Yujing Di Yujing Di Tingting Guo Tingting Guo Jeffrey E. Ming Jeffrey E. Ming Fangyuan Kong Fangyuan Kong Huiqiu Yin Huiqiu Yin Linlin Zhang Linlin Zhang Fang Xie Fang Xie Na Yang Na Yang Chuan Ping Chuan Ping Yi Li Yi Li Jie Hou Jie Hou Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination With Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study Adis Journals 2020 Acetylsalicylic acid Bioequivalence Clopidogrel Co-Plavix Fixed dose combination RSABE 2020-05-14 09:46:37 Media https://adisjournals.figshare.com/articles/media/Implementation_of_a_Reference-Scaled_Average_Bioequivalence_Approach_for_Highly_Variable_Acetylsalicylic_Acid_in_Fixed-Dose_Combination_With_Clopidogrel_Versus_Enteric_Aspirin_in_Chinese_Subjects_Under_Fasting_Conditions_A_Phase_1_Open-Labe/12206147 <p>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.</p> <p> </p>